Sanjaya Satapathy

Sanjaya Satapathy

Feinstein Institute for Medical Research - Manhasset / United States
Medical and Health Sciences / General Surgery
AD Scientific Index ID: 4607364
person_outline Sanjaya Satapathy's MOST POPULAR ARTICLES
1-) Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worseningV Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ...Gastroenterology 150 (5), 1147-1159. e5, 20169262016
2-) Epidemiology and natural history of nonalcoholic fatty liver diseaseSK Satapathy, AJ SanyalSeminars in liver disease 35 (03), 221-235, 20153882015
3-) Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trialsSA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ...Journal of hepatology 73 (1), 26-39, 20203722020
4-) Beneficial effects of tumor necrosis factor-α inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitisSK Satapathy, S Garg, R Chauhan, P Sakhuja, V Malhotra, BC Sharma, ...Official journal of the American College of Gastroenterology| ACG 99 (10 …, 20042832004
5-) A randomized controlled trial of lamivudine to treat acute hepatitis BM Kumar, S Satapathy, R Monga, K Das, S Hissar, C Pande, BC Sharma, ...Hepatology 45 (1), 97-101, 20072722007